Friday, April 29, 2011

NeurogesX CEO Anthony DiTonno to retire

NeurogesX Inc. President and CEO Anthony DiTonno, who led the company through FDA approval of its Qutenza pain patch, will retire by the end of the year.
“I have been CEO of NeurogesX for more than eight years and we have accomplished the objectives I established for myself when I joined the company in March 2003” as chief operating officer, DiTonno said in a press release Friday by the San Mateo company (NASDAQ: NGSX).

No comments:

Post a Comment